Reaction
Pulmonary Interstitial Emphysema Syndrome reporting signals
As of the last recalculation, Pulmonary Interstitial Emphysema Syndrome appears in 141 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is RIFAMPICIN (PRR 380.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rifampicin | 22 | 380.2 | 381.0 |
| Daptomycin | 15 | 268.5 | 268.9 |
| Cholestyramine | 19 | 267.9 | 268.4 |
| Valganciclovir Hydrochloride Powder, | 11 | 144.3 | 144.4 |
| Piperacillin And Tazobactam | 11 | 137.6 | 137.7 |
| Dutasteride | 7 | 133.7 | 133.8 |
| Linezolid | 22 | 129.1 | 129.2 |
| Rifampin | 9 | 97.1 | 97.2 |
| Carfilzomib | 10 | 56.1 | 56.1 |